Key result
Young maternal age, high-risk occupation (20.0% vs 11.7%, P=0.04), CMV IgG seroconversion (83.1% vs 63.3%, P=0.005), and abnormal fetal MRI (11.6% vs 0%, P=0.003) predicted symptomatic CMV disease.
Why the study?
What are the antenatal risk factors associated with symptomatic congenital CMV disease following primary maternal CMV infection?
Cohort (n=155)
What are the antenatal risk factors associated with symptomatic congenital CMV disease following primary maternal CMV infection?
Young maternal age, high-risk occupation, CMV IgG seroconversion at diagnosis, and abnormal fetal MRI are prognostic risk factors for symptomatic congenital CMV disease.
OBJECTIVES: This study aimed to evaluate antenatal risk factors associated with symptomatic congenital cytomegalovirus (CMV) disease, following in utero vertical infection. METHODS: This study included a retrospective cohort of 155 neonates with congenital CMV infection, following primary maternal CMV infection during pregnancy, and were divided to symptomatic (n=95) and asymptomatic (n=60) newborns. RESULTS: Young maternal age (29.1±5.12 vs. 31.6±5.36 years, P=0.005), high risk occupation for viral exposure (20.0% vs. 11.7%, P=0.04), CMV IgG seroconversion at diagnosis (83.1% vs. 63.3%, P=0.005) and abnormal fetal MRI (11.6% vs. 0%, P=0.003) were found to be prognostic risk factors associated with symptomatic CMV disease of the newborn. Maternal febrile illness at diagnosis, IgG avidity, US findings and the timing of maternal infection were not associated with the occurrence of neonatal symptoms. CONCLUSIONS: Knowledge of the reported risk factors may assist in counseling parents with intra uterine CMV infection.
No takes yet. Share an insight, caveat, or question.
Hadar et al. (2015) conducted a cohort in Congenital CMV infection (n=155). Antenatal risk factors (e.g., young maternal age, high-risk occupation, abnormal fetal MRI) vs. Absence of risk factors was evaluated on Symptomatic congenital CMV disease. Young maternal age, high-risk occupation (20.0% vs 11.7%, P=0.04), CMV IgG seroconversion (83.1% vs 63.3%, P=0.005), and abnormal fetal MRI (11.6% vs 0%, P=0.003) predicted symptomatic CMV disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: